MTOR and cancer: Therapies targeting oncogenic kinases have provided promising results in inhibiting proliferation of cancer cells, and some kinases have been targeted in preclinical and clinical studies in childhood sarcomas (as reviewed in Wachtel et al. [11]), e.g. IGF1R and mTOR [12,13].